Business Context and Reporting Period
Company: Curis, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: April 28, 2004
Reporting Period: Three months ended March 31, 2004
Curis, Inc. filed this report to announce its financial results for the first quarter of fiscal year 2004. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained within the attached press release (Exhibit 99.1), which is not included in the provided source text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative analysis.
Guidance, Outlook, and Risks
The filing text does not contain specific management commentary, guidance, outlook, risks, contingencies, or unusual items. The report serves primarily as a notification that the results have been announced and directs readers to the attached exhibit for full details.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 28, 2004) for specific revenue and net loss figures.
- Verify cash position and burn rate details in the attached press release.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the full announcement.
- Confirm if the filing includes any forward-looking statements or revised guidance not present in the 8-K summary.